VITAMIN E AND OXIDATIVE STRESS MODULATION IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: CURRENT EVIDENCE AND CLINICAL PERSPECTIVES

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), encompasses a spectrum from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. It is strongly associated with metabolic syndrome, obesity, and insulin resistance.